<DOC>
	<DOCNO>NCT02217670</DOCNO>
	<brief_summary>The main purpose study assess comparative bioavailability test formulation Metformin HCl 1000 mg granule manufacture Indeus Life Sciences Pvt . Ltd. , Mumbai India ( An Affiliate Of Disphar International B.V. , The Netherlands ) relative Glucophage 1000 mg film-coated tablet Merck GmbH , Austria 54 healthy adult subject feed condition . The second aim ass safety subject determine pharmacokinetic data .</brief_summary>
	<brief_title>Comparative Bioavailability Study Metformin HCl 1000 mg Granules v Glucophage 1000 mg Film-coated Tablet</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<criteria>1 . Age 18 50 year , inclusive . 2 . Body Mass Index ( BMI ) range within 18.5 30.0 Kg/m2 . 3 . Subject know allergy drug investigation ingredient related drug . 1 . Medical demographic perform longer two week initiation clinical study significant deviation normal range . 2 . Results laboratory test outside normal range HbA1c test liver kidney function test ( Creatinine level ALP accept reference range ) outside reference range Hb RBC index ( MCV , MCH , MCHC ) deviation outside 5 % reference range . 3 . Acute infection within one week precede first study drug administration . 4 . History drug alcohol abuse . 5 . Subject heavy smoker ( 10 cigarette per day ) . 6 . Subject agree take prescription nonprescription drug within two week precede first study drug administration donate last sample study . 7 . Subject agree take vitamin take nutritional purpose within two day first study drug administration donate last sample study . 8 . Subject special diet ( example subject vegetarian ) . 9 . Subject consumes large quantity alcohol beverage contain methylxanthines e.g . caffeine ( coffee , tea , cola , chocolate etc ) . 10 . Subject agree consume beverage food contain alcohol 48 hour prior study drug administration donate last sample respective period . 11 . Subject agree consume beverage food contain methylxanthines e.g . caffeine ( coffee , tea , cola , chocolate etc . ) 24 hour prior study drug administration end confinement period . 12 . Subject agree consume beverage food contain grapefruit 7 day prior first study drug administration donate last sample study . 13 . Subject history severe disease direct impact study . 14 . Participation bioequivalence/bioavailability study clinical study within last 80 day first study drug administration . 15 . Subject intend hospitalize within 3 month first study drug administration . 16 . Subjects donate blood derivative past 3 month completion study , would donate 1250 ml 120 day , 1500 ml 180 day , 2000 ml 270 day , 2500 ml blood 1 year . 17 . The female subject pregnant lactating . 18 . Subject history significant asthma , peptic gastric ulcer , sinusitis , pharyngitis , renal disorder ( impaired renal function ) , hepatic disorder ( impaired hepatic function ) , cardiovascular disorder , neurological disease epilepsy , haematological disorder , type I diabetes diabetic ketoacidosis , lactic acidiosis , Vitamin B12 deficiency , psychiatric , dermatologic , immunological disorder surgery . 19 . Subject agree engage strenuous exercise least one day prior study drug administration . 20 . Subject screen examination pulse outside normal range ( 60100 beat per minute ) body temperature outside normal range ( 36.437.7 â—‹C ) respiratory rate outside normal range ( 1420 breath per minute ) sit blood pressure le 100/60 mm Hg equal 140/90 mm Hg . 21 . Subject history difficulty swallow gastrointestinal disease could affect drug absorption . 22 . Subject undergo radiologic study involve intravascular administration iodinate contrast material ( example , intravenous urogram , intravenous cholangiography , angiography , compute tomography ( CT ) scan intravascular contrast material ) . 23 . Fasting blood sugar screen less 70 mg/dl . 24 . Subject diabetes mellitus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>